GILEAD SCIENCES, INC. — Director's Dealing 2017

Jul 25, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2017-07-21

Reporting Person: Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-07-21	Common Stock	M	34500	$26.99	Acquired	137488	Direct
2017-07-21	Common Stock	S	34500	$74.00	Disposed	102988	Direct
2017-07-21	Common Stock	S	5500	$74.00	Disposed	97488	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-07-21	Non-qualified Stock Option (Right to Buy)	$26.99	M	34500	Disposed	2018-07-30	Common Stock (34500)	Direct

Footnotes

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: Options vest over a five year period with 20% vesting July 30, 2009, the first anniversary of the grant. The options continue to vest in quarterly installments over the next four years, and will be fully vested on July 30, 2013.